Concomitantly, MSCs-derived CCL5 binding to CCR5 on breast cancer cells result in the secretion of CSF1, which in turn binds to the CSF1 receptor on MSCs to recruit tumor-associated immune cells [129]. This evidence concerns the gene CCL5 and neoplasm.